Within this context, among the developed CRY stabilizers, the most promising compound SHP656, derived from KL001, has been found to specifically inhibit the growth of patient-derived glioblastoma stem cells in vitro, without impacting on differentiated glioblastoma cells or non-malignant epilepsy-derived neural cells145. This evidence concerns the gene CRYL1 and glioblastoma.